nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabilone—Eye swelling—Cyclosporine—focal segmental glomerulosclerosis	0.0671	0.0772	CcSEcCtD
Nabilone—Bacterial infection—Cyclosporine—focal segmental glomerulosclerosis	0.0474	0.0545	CcSEcCtD
Nabilone—Cerebration impaired—Cyclosporine—focal segmental glomerulosclerosis	0.0372	0.0428	CcSEcCtD
Nabilone—Tongue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0301	0.0346	CcSEcCtD
Nabilone—Disturbance in attention—Cyclosporine—focal segmental glomerulosclerosis	0.0253	0.029	CcSEcCtD
Nabilone—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.0211	0.0243	CcSEcCtD
Nabilone—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.02	0.023	CcSEcCtD
Nabilone—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.019	0.0218	CcSEcCtD
Nabilone—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.0178	0.0204	CcSEcCtD
Nabilone—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.017	0.0195	CcSEcCtD
Nabilone—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.0169	0.0194	CcSEcCtD
Nabilone—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.0168	0.0193	CcSEcCtD
Nabilone—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.0168	0.0193	CcSEcCtD
Nabilone—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.0156	0.018	CcSEcCtD
Nabilone—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.015	0.0173	CcSEcCtD
Nabilone—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.0141	0.0162	CcSEcCtD
Nabilone—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.0134	0.0154	CcSEcCtD
Nabilone—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.0127	0.0146	CcSEcCtD
Nabilone—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.0122	0.014	CcSEcCtD
Nabilone—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.0119	0.0137	CcSEcCtD
Nabilone—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.0115	0.0133	CcSEcCtD
Nabilone—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.0109	0.0126	CcSEcCtD
Nabilone—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.0109	0.0125	CcSEcCtD
Nabilone—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.0106	0.0122	CcSEcCtD
Nabilone—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.0102	0.0118	CcSEcCtD
Nabilone—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.0102	0.0117	CcSEcCtD
Nabilone—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00986	0.0113	CcSEcCtD
Nabilone—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00982	0.0113	CcSEcCtD
Nabilone—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00939	0.0108	CcSEcCtD
Nabilone—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00929	0.0107	CcSEcCtD
Nabilone—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00902	0.0104	CcSEcCtD
Nabilone—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00896	0.0103	CcSEcCtD
Nabilone—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00888	0.0102	CcSEcCtD
Nabilone—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00884	0.0102	CcSEcCtD
Nabilone—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00879	0.0101	CcSEcCtD
Nabilone—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00863	0.00991	CcSEcCtD
Nabilone—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00859	0.00988	CcSEcCtD
Nabilone—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00856	0.00984	CcSEcCtD
Nabilone—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00835	0.00959	CcSEcCtD
Nabilone—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00829	0.00952	CcSEcCtD
Nabilone—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00826	0.00949	CcSEcCtD
Nabilone—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00814	0.00936	CcSEcCtD
Nabilone—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00814	0.00936	CcSEcCtD
Nabilone—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00814	0.00936	CcSEcCtD
Nabilone—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00812	0.00933	CcSEcCtD
Nabilone—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00805	0.00925	CcSEcCtD
Nabilone—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00796	0.00915	CcSEcCtD
Nabilone—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00787	0.00905	CcSEcCtD
Nabilone—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00776	0.00891	CcSEcCtD
Nabilone—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00755	0.00867	CcSEcCtD
Nabilone—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00744	0.00855	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00711	0.00817	CcSEcCtD
Nabilone—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00706	0.00811	CcSEcCtD
Nabilone—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00701	0.00806	CcSEcCtD
Nabilone—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00696	0.008	CcSEcCtD
Nabilone—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00694	0.00798	CcSEcCtD
Nabilone—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00687	0.0079	CcSEcCtD
Nabilone—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00679	0.0078	CcSEcCtD
Nabilone—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00673	0.00773	CcSEcCtD
Nabilone—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00668	0.00767	CcSEcCtD
Nabilone—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00668	0.00767	CcSEcCtD
Nabilone—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00643	0.00739	CcSEcCtD
Nabilone—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00638	0.00734	CcSEcCtD
Nabilone—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00617	0.00709	CcSEcCtD
Nabilone—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00617	0.00709	CcSEcCtD
Nabilone—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00575	0.00661	CcSEcCtD
Nabilone—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.0056	0.00644	CcSEcCtD
Nabilone—CNR2—G alpha (i) signalling events—AGTR2—focal segmental glomerulosclerosis	0.00554	0.0427	CbGpPWpGaD
Nabilone—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00552	0.00635	CcSEcCtD
Nabilone—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00534	0.00614	CcSEcCtD
Nabilone—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00516	0.00593	CcSEcCtD
Nabilone—CNR2—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.00514	0.0397	CbGpPWpGaD
Nabilone—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00496	0.0057	CcSEcCtD
Nabilone—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00492	0.00566	CcSEcCtD
Nabilone—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00492	0.00565	CcSEcCtD
Nabilone—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00489	0.00562	CcSEcCtD
Nabilone—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00464	0.00533	CcSEcCtD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00441	0.034	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—AGTR2—focal segmental glomerulosclerosis	0.00435	0.0335	CbGpPWpGaD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.00404	0.0311	CbGpPWpGaD
Nabilone—CNR2—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00396	0.0305	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—SPP1—focal segmental glomerulosclerosis	0.00386	0.0297	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00346	0.0267	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00339	0.0261	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00336	0.0259	CbGpPWpGaD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.0031	0.0239	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.003	0.0231	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00287	0.0221	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00266	0.0205	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00263	0.0203	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00258	0.0199	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00239	0.0184	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.00235	0.0181	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00225	0.0174	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00219	0.0169	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00203	0.0156	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00191	0.0147	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.0019	0.0146	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00187	0.0144	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00182	0.014	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00179	0.0138	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00173	0.0134	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00172	0.0133	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00172	0.0132	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00165	0.0127	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00159	0.0123	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.0015	0.0115	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00149	0.0115	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00146	0.0112	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00145	0.0112	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00143	0.011	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00141	0.0108	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00139	0.0107	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00136	0.0105	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00135	0.0104	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00132	0.0102	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00129	0.00996	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00125	0.00965	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00124	0.00953	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00114	0.00882	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00114	0.00876	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00112	0.00866	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00109	0.00842	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00104	0.00801	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00103	0.00791	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00102	0.00789	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00102	0.00784	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00097	0.00748	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000932	0.00718	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000881	0.00679	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000856	0.00659	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000805	0.00621	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000803	0.00619	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000798	0.00615	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000782	0.00603	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000731	0.00564	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000671	0.00517	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000663	0.00511	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000644	0.00496	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000614	0.00473	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.00061	0.0047	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000551	0.00424	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000521	0.00401	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000509	0.00392	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000505	0.00389	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000478	0.00369	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000432	0.00333	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000423	0.00326	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000399	0.00308	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000332	0.00256	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000324	0.0025	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000267	0.00206	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000254	0.00196	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.00021	0.00162	CbGpPWpGaD
